Microdosimetry plays an important role in the clinical application of boron neutron capture therapy (BNCT).
微剂量学研究在临床硼中子俘获治疗(BNCT)的计划设计和疗效评价中起着重要作用。
Boron neutron capture therapy(BNCT), a new cure for cancer, appeared in 60 's, which consists of polytechniques and manifold subjects.
硼中子俘获疗法是60年代兴起的治疗恶性肿瘤的新方法，属于多学科多技术相结合的一门应用科学。
A special medical therapy reactor (MTR) is required for boron neutron capture therapy (BNCT), which has extended progress in some therapy tests.
正在试验和研究中的硼中子治疗术(BNCT)，要求设计专用反应堆，以适应大规模治疗的需要。
Objective to investigate the induction effect of the boron neutron capture therapy (BNCT) on apoptosis of human brain glioma U251 cells in vitro and the possible mechanisms.
目的研究硼中子俘获疗法(BNCT)能否诱导体外培养的U 251细胞发生凋亡，并探讨其诱导细胞凋亡的机制。
Objective to investigate the induction effect of the boron neutron capture therapy (BNCT) on apoptosis of human brain glioma U251 cells in vitro and the possible mechanisms.
目的研究硼中子俘获疗法(BNCT)能否诱导体外培养的U 251细胞发生凋亡，并探讨其诱导细胞凋亡的机制。
应用推荐